Navigation Links
DaVita to Present Three Abstracts for the International Society for Peritoneal Dialysis
Date:8/26/2009

DENVER, Aug. 26 /PRNewswire-FirstCall/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research(R), today announced that it will present three abstracts at the 3rd North American Chapter meeting of the International Society for Peritoneal Dialysis (ISPD) on August 27-29 in Vancouver, British Columbia.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

ISPD provides leading renal health care providers with the opportunity to advance their knowledge of peritoneal dialysis (PD) and to promote advancement of such knowledge through international meetings and scientific publications.

The presentations will highlight subjects critical to physicians, nurses and other practitioners in the field of PD, including:

  • A DaVita(R) pilot program evaluating ESA use in PD patients and how to ensure patient adherence while maintaining hemoglobin outcomes;
  • Access to Peritoneal Dialysis: Overcoming Obstacles for Uninsured, Unencountered Patients - a look at how changes in PD clinic infrastructure and the industry's perception would increase usage of this valuable treatment method;
  • The Post-Peritonitis Checklist: Beyond Pharmacological Treatment - an analysis of the impact implementing a step-by-step checklist of pre-existing and innovative interventions into patient care practices resulted in reduced peritonitis rates.

"DaVita is committed to leading the renal community in seeking out new and innovative ways to improve clinical outcomes for patients with kidney disease," said Allen R. Nissenson MD, Chief Medical Officer at DaVita. "The three abstracts being presented at this meeting reflect DaVita's success in driving quality improvement for patients."

DaVita and DaVita Clinical Research are registered trademarks of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita has been recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Workplaces(TM). As of June 30, 2009, DaVita operated or provided administrative services at 1,493 outpatient dialysis facilities and acute units in approximately 700 hospitals located in 43 states and the District of Columbia, serving approximately 116,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The City of Tacoma Announces Official DaVita Day
2. DaVita Only Dialysis Provider Named on EPAs FORTUNE 500 List of Green Power Purchasers
3. DaVita Hosts National Quality Week 2009
4. DaVita Donates Toys, Shoes and School Supplies for Army National Guard to Distribute in Iraq
5. Mayor Julian Jolly Reseueollo Dialysis Center Officially Opens Doors With Support From Bridge of Life - DaVita Medical Missions
6. Six DaVita Clinics in Colorado Receive Silver Award for Clinical Excellence
7. DaVita Clinical Research Appoints Mahesh Krishnan as Vice President
8. DaVitas Award-Winning Training Program for New Teammates Reaches Milestone With 100th DaVita Academy in Baltimore, Maryland
9. DaVita Celebrates the Opening of Its 1,500th Outpatient Kidney Care Clinic in the United States
10. DaVita.com Provides Easy Recipes to Plan Your Fathers Day Dinner
11. DaVita Launches First Corporate Social Responsibility Report With Nationwide Community Service Blitz
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Vail knee specialist ... Leaders to Know in 2016 . The list consists of physicians establishing, leading and ... establish this list. , An Ambulatory Surgery Center, also known as an ASC, ...
(Date:2/12/2016)... ... 12, 2016 , ... Miami Dental Specialists is excited to bring patients the ... Beginning in January, Miami Dental Specialists will offer the non-metal implants as a safe, ... to be chosen by the dental implant manufacturer, Straumann, to bring this cutting-edge technology ...
(Date:2/12/2016)... Grants Pass, OR (PRWEB) , ... February 12, ... ... website contains an article about foods choices that promote eye health. These articles ... optimal vision health. Water and health advocate Sharon Kleyne endorses every one of ...
(Date:2/12/2016)... ... February 12, 2016 , ... A lot has been reported about the ... has access to health and wellness resources most Americans could ever dream of having ... has a schedule as frenetic as the U.S. President. , In honor of ...
(Date:2/12/2016)... Texas (PRWEB) , ... February 12, 2016 , ... Yisrayl ... a revealing article this week that uncovers what he says are the real facts ... stories of the Bible from parents and Sunday school teachers, and Yisrayl says there ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... --> ... Global Clinical Trials Review, H2, 2015 provides an ... trials landscape along with top level data related ... & E7), Trial Status, Trial Phase, Sponsor Type ... involved and enlists all trials (Trial title, Phase, ...
(Date:2/11/2016)... 11, 2016 Stem cells are primitive cells ... self-renewal and the capacity to differentiate into mature cell ... as the first mouse embryonic stem cells were derived ... 1995 that the first culturing of embryonic stem cells ... not produced until 2006 As a result of these ...
(Date:2/11/2016)... -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical ... pets, today announced the submission to FDA of the ... (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline results ... the control of pyrexia (fever) in horses were recently ... --> The Chemistry, Manufacturing, and Controls technical ...
Breaking Medicine Technology: